PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
 
PLoS One. 2017; 12(7): e0181899.
Published online 2017 July 28. doi:  10.1371/journal.pone.0181899
PMCID: PMC5533440

Mechanical versus humoral determinants of brain death-induced lung injury

Asmae Belhaj, Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing,1,2,* Laurence Dewachter, Conceptualization, Data curation, Formal analysis, Investigation, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing,2 Sandrine Rorive, Data curation, Formal analysis, Investigation, Resources, Validation, Visualization, Writing – original draft, Writing – review & editing,3,4 Myriam Remmelink, Data curation, Formal analysis, Investigation, Resources, Validation, Visualization, Writing – original draft, Writing – review & editing,3 Birgit Weynand, Data curation, Formal analysis, Investigation, Validation, Visualization, Writing – original draft, Writing – review & editing,5 Christian Melot, Data curation, Formal analysis, Methodology, Software, Validation, Visualization, Writing – original draft, Writing – review & editing,2,6 Emeline Hupkens, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization,2 Céline Dewachter, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft,2 Jacques Creteur, Formal analysis, Funding acquisition, Investigation, Resources, Validation, Visualization, Writing – original draft,7 Kathleen Mc Entee, Data curation, Formal analysis, Investigation, Resources, Validation, Visualization, Writing – original draft,2 Robert Naeije, Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing,2 and Benoît Rondelet, Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing1,2
Partha Mukhopadhyay, Editor

Abstract

Background

The mechanisms of brain death (BD)-induced lung injury remain incompletely understood, as uncertainties persist about time-course and relative importance of mechanical and humoral perturbations.

Methods

Brain death was induced by slow intracranial blood infusion in anesthetized pigs after randomization to placebo (n = 11) or to methylprednisolone (n = 8) to inhibit the expression of pro-inflammatory mediators. Pulmonary artery pressure (PAP), wedged PAP (PAWP), pulmonary vascular resistance (PVR) and effective pulmonary capillary pressure (PCP) were measured 1 and 5 hours after Cushing reflex. Lung tissue was sampled to determine gene expressions of cytokines and oxidative stress molecules, and pathologically score lung injury.

Results

Intracranial hypertension caused a transient increase in blood pressure followed, after brain death was diagnosed, by persistent increases in PAP, PCP and the venous component of PVR, while PAWP did not change. Arterial PO2/fraction of inspired O2 (PaO2/FiO2) decreased. Brain death was associated with an accumulation of neutrophils and an increased apoptotic rate in lung tissue together with increased pro-inflammatory interleukin (IL)-6/IL-10 ratio and increased heme oxygenase(HO)-1 and hypoxia inducible factor(HIF)-1 alpha expression. Blood expressions of IL-6 and IL-1β were also increased. Methylprednisolone pre-treatment was associated with a blunting of increased PCP and PVR venous component, which returned to baseline 5 hours after BD, and partially corrected lung tissue biological perturbations. PaO2/FiO2 was inversely correlated to PCP and lung injury score.

Conclusions

Brain death-induced lung injury may be best explained by an initial excessive increase in pulmonary capillary pressure with increased pulmonary venous resistance, and was associated with lung activation of inflammatory apoptotic processes which were partially prevented by methylprednisolone.

Introduction

Brain death (BD) induced lung injury also called neurogenic pulmonary edema (NPE) is an acute condition which follows closely a variety of insults to the central nervous system that cause acute, rapid, abrupt and extreme increase in intracranial pressure (ICP) [13]. The pathophysiology linking the neurologic, cardiac, and pulmonary conditions in NPE remains debated.

The abrupt increase in ICP leading to neuronal compression, ischemia or damage is believed to give rise to an intense activation of the sympathetic nervous system and the release of catecholamines [4].

The autonomic response to elevated ICP plays an important role in the pathogenesis of NPE, however, what occurs mechanistically at the level of the pulmonary vascular endothelium remains uncertain and theoretical. Several clinicopathologic paradigms have been proposed to explain the clinical syndrome of NPE.

In the neuro-cardiac theory, the catecholamines storm following the neurologic insult leads to direct toxic myocardial injury as described in the Takotsubo’s cardiomyopathy and the development of pulmonary edema [5].

The neuro-hemodynamic and the “blast” posit that the severe abrupt increases in systemic and pulmonary pressures following the catecholamine surge result in a net shift of blood volume from the systemic circulation to the low resistance pulmonary circulation. This increase in pulmonary venous pressure leads to the development of transudative pulmonary edema [6]. The “blast theory” further posits that the acute rise in capillary pressure induces a degree of barotrauma capable of damaging the capillary-alveolar membrane [3]. And the “pulmonary venule adrenergic hypersensitivity” hypothesis is that the massive sympathetic discharge following ICP directly affects the pulmonary vascular bed with pulmonary venoconstriction or endothelial disruption responsible for the formation of pulmonary edema [2].

Moreover, the early autonomous storm accompanying brain death triggers the development of a systemic and pulmonary inflammatory response, which may lead, by itself, to increased pulmonary endothelial permeability [7,8] and sympathetic vasoconstriction of systemic and pulmonary vessels.

Finally, besides this initial neurogenic pulmonary edema development, occurrence of severe cardiac dysfunction and/or large vascular filling could aggravate lung function alteration by conjunction of a hydrostatic component.

A better characterization and quantification of a single “primum movens” of brain death induced lung injury would be of therapeutic relevance, and could also help to improve the survival of transplanted brain-death donor lungs [7,9].

We therefore investigated the biology and the pathophysiology of lung injury in a pig model of brain death [10]. Pulmonary capillary pressure (PCP) as a determinant of hydrostatic lung edema was determined from the analysis of pressure decay curves after single pulmonary arterial occlusion [11]. Lung tissue was sampled to quantify gene expressions and, when possible, protein levels of pro- and anti-inflammatory mediators thought to be involved in prolonged brain death induced lung injury as a permeability lung lesion [12], i.e. a SDRA variant [13]. The experiments were performed with and without preventive administration of methylprednisolone to blunt the humoral participation to brain death induced lung injury pathophysiology [14]. High-dose corticosteroids are standard practice in lung transplantation and have indeed been shown to improve the quality of brain-death donor lungs, presumably through non-specific anti-inflammatory effects [15].

Materials and methods

The present study was approved by Institutional Ethics Committee on Animal Welfare at the Faculty of Medicine of the Université Libre de Bruxelles (Brussels, Belgium; protocol number: 510N) and was done in accordance with the “Guiding Principles in Care and Use of Animals” of the American Physiologic Society. The animals were delivered the day before the experiments by an approved breeder (Jan Derook Farm, Belgium) and have been placed under a water diet for six hours before anesthesia.

Animal preparation

Female pigs (aged 4–5 months), weighting 43 ± 1 kg, were premedicated with intramuscular 20 mg.kg-1 ketamine and 0.1 mmg.kg-1 midazolam, anesthetized with intravenous 1 mg.kg-1 midazolam and 15 mg.kg-1 remifentanil and paralyzed for thoracotomy with intravenous 0.2 mg.kg-1.hour-1 rocuronium bromide. Anaesthesia was maintained during the protocol with intravenous 0.1 mg.kg-1.hour-1 midazolam and 7.5 mg.kg-1.hour-1 remifentanil. Animals were ventilated with an inspired oxygen fraction (FiO2) of 0.4 to 1.0 to maintain arterial oxygen saturation (SaO2) > 90%, a respiratory rate of 12–20 breaths.min-1 and a tidal volume of 15–25 mL.kg-1 to achieve an arterial PaCO2 between 35 and 45 mmHg, and a positive end-expiratory pressure (PEEP) between 5 and 8 cm H2O [9].

A flow-directed balloon-tipped pulmonary artery catheter (131H-7F; Baxter-Edwards, Irvine, CA, USA) was inserted via the left external jugular vein and positioned in the pulmonary artery for measurements of pulmonary artery pressure (PAP), wedged PAP (PAWP), right atrial pressure (RAP), PCP computed from the PAP decay curve after arterial balloon occlusion, thermodilution cardiac output (CO), and central body temperature, and for mixed venous blood sampling. A polyethylene catheter was inserted in the thoracic aorta via the right carotid artery to measure systemic artery pressure (SAP) and to sample arterial blood. Balanced crystalloid and gelatin modified solutions were perfused (at 10 mL.kg-1.hour—1) to maintain RAP between 6 and 8 mmHg. When the SAP < 65mmHg, infusion of norepinephrine was started to maintain blood pressure.

Brain death procedure

The pigs were randomly assigned to an intravenous administration of placebo (BD group; n = 11) or 15 mg.kg-1 methylprednisolone sodium succinate (Solumedrol®, Pfizer, Ireland; BD + corticosteroids group; n = 8). A hole was drilled in the temporo-parietal region of the cranium. Slow parenchymal infusion (1.5 mL/min; 150 min) of autologous blood was performed through an 18-gauge SURFLO® catheter (TERUMO®, SR-OX1851CA) subdurally inserted to induce brain death and to record intracranial pressure (B). One hour after Cushing reflex response, i.e. a sharp increase in SAP with decreased HR [16], which lasted between 30 and 60 minutes, brain death was objectivated following standard criteria [17,18]: a) deep coma, excluding reversible factors such as anesthesia and hypothermia; b) absence of oculopupillary and corneal reflexes on two occasions; c) loss of spontaneous breathing with positive apnea testing; and d) no increase in HR after 1 mg of atropine.

Anesthesia and paralysis were withheld when the Cushing reflex was observed. After objectivation of brain death, protective ventilation was applied with tidal volume of 6 mL/kg and target plateau pressures <30 cmH2O and periodic deep inspirations were administered to prevent atelectasis.

Hemodynamic measurements

A first data set was obtained at baseline after 20 min postoperative stabilization as assessed by stable heart rate (HR), SAP, PAP and CO. A second and a third data set were obtained respectively 1 hour and 5 hours after the Cushing reflex response, and defined as BD + 1h and BD + 5h. Finally, the animals were euthanized by pentobarbital sodium (Nembutal®, Oak, USA) overdose and lung tissue was sampled, immediately snap-frozen and stored at –80°C for pathobiological evaluation and, after overnight fixation, embedded in paraffin for immunohistochemistry.

Each data set included blood gas analysis and acquisition of SAP, PAP, PAWP, RAP, PCP and CO. After the acquisition of each data set, systemic arterial plasma was collected and lung biopsied using Endo-GIA™ 30mm Reload (Covidien, Ireland) in the upper left pulmonary lobe.

PCP and resulting venous compartmental resistance (Rv) was computed in triplicate by a dual-exponential fitting of the pressure decay curve obtained after pulmonary arterial balloon occlusion, as previously reported [11,19].

Biological and histological assessments

Real-time quantitative polymerase chain reaction (RTQ-PCR)

Total RNA was extracted from snap-frozen lung tissue using the QIAGEN RNeasy® Mini kit (QIAGEN, Hilden, Germany), according to the manufacturer’s instructions. Total RNA content was determined by standard spectrophotometric techniques and RNA integrity was assessed by visual inspection of Gel Red (Biofilm, Hayward, CA)-stained agarose gels. Reverse transcription was performed using random primers and SuperscriptTM II Reverse Transcriptase (Invitrogen, Carlsbad, CA, USA), according to the manufacturer’s instructions.

For RTQ-PCR, sense and antisense primers were designed using Primer3 program for sus scrofa tumor necrosis factor (TNF)-α, interleukin(IL)-6, IL-10, IL-1beta (IL-1β), IL-8, hypoxia inducible factor-1-alpha (HIF-1α), heme oxygenase-1 (HO-1), glutathion peroxidase-1 (GPx-1), oxidative-stress responsive-1 (OXSR-1), intercellular adhesion molecule (ICAM)-1, vascular cell adhesion protein (VCAM)-1, Bax, Bcl-2 and hypoxanthine phosphoribosyl transferase (HPRT)-1, β-actin (ACTB), TATA box binding protein (TBP1) and ribosomal protein L4 (RPL4), used as housekeeping genes as previously reported [20] (Table 1). To avoid inappropriate amplification of residual genomic DNA, intron-spanning primers were selected when exon sequences were known and analysis was run to check if primer pairs were selected when exon sequences were known and analysis was run to check if primer pairs were only matching the sequence of interest. For each sample, amplification reaction was performed in triplicate using SYBR-Green PCR Master Mix (Quanta Biosciences, Gaithersburg, MD, USA), specific primers and diluted template cDNA. Result analysis was performed using iCycler System (Bio-Rad Laboratories). Relative mRNA quantification was achieved using the Pfaffl method [21] by normalization with the housekeeping genes.

Table 1
Primers used for RTQ-PCR in porcine lung tissue.

Protein extraction and Enzyme-linked immunosorbent assay (ELISA)

Proteins were extracted from snap-frozen lung tissue by homogenization in an appropriate ice-cold lysis buffer. After centrifugation, protein concentration was determined using the Bradford method with Bio-Rad protein Assay (Bio-Rad, Temse, Belgium). Protein levels of IL-6, IL-10 and IL-1β were determined with Multiplex Assay (MILLIPLEXMAP Porcine Cytokine/Chemokine Magnetic Bead Panel, Merck Millipore, Darmstadt, Germany) in total lung homogenates and in systemic arterial serum, according to manufacturer’s instructions. Cytokine concentrations were obtained by referring to a standard curve realized in parallel. Results represented the mean value of two separate measurements performed in duplicate.

Immunohistochemistry–Lung evaluation of inflammatory cell infiltrates

Immunohistochemistry were performed as previously described [10]. After progressive rehydration, 5μm-sections of lung tissue fixed and embedded in paraffin were incubated in target retrieval buffer (Dako, Glostrup, Denmark) and heated in a bath for 20 minutes at 95°C for target retrieval. Endogenous peroxidase activity was quenched with hydrogen peroxide in phosphate buffered saline (PBS; 5%) for 10 minutes, and the sections were blocked by incubation with bovine serum albumin in PBS (3%) for 30 minutes. Sections were allowed to react for 60 minutes at 37°C with polyclonal anti-Pig myeloperoxidase (MPO) (Abcam, Cambridge, UK) antibodies diluted at 1/100 in PBS. Sections were then incubated with biotinylated anti-rabbit IgG at 1/200 (Vector Laboratories, Burlingame, U.S.A.) and subsequently with streptavidin–peroxidase (Dako). Antibody binding was detected with a liquid DAB (diaminobenzidine) substrate kit (AbCys Biology, Paris, France). The appearance of a brown reaction product was observed under a light microscope. Tissues were counterstained with hematoxylin (Sigma-Aldrich, St Louis, MO). Negative controls run without the primary antibody were tested and were found to be negative.

In each lung tissue slide and for each staining, twenty microscopic fields (light microscopy, X400 magnification) were randomly chosen.

The number of extravascular neutrophils (MPO-positive) was counted. Intravascular inflammatory cells were excluded. The total surface of each sample was then measured using ImageJ software. The average numbers of extravascular inflammatory cells per mm2 were then calculated as the total score for each specimen. Two investigators, who were blinded to the assigned group, did all cell counts independently. The mean value was used for analysis.

Immunohistochemistry—Terminal deoxynucleotidyl transferase dUTP nick-end labelling (TUNEL)

Lung epithelial cells undergoing apoptosis were detected by TUNEL staining using the ApopTag® Plus Peroxidase In Situ Apoptosis Detection Kit (EMD Millipore, Temecula, CA, USA), as previously described [22]. Negative control run without TdT enzyme and positive control pre-treated with DNase were tested. For each tissue specimen, twenty randomly chosen fields were examined. Lung epithelial apoptotic rate was calculated as the ratio of apoptotic cells (TUNEL-positive or brown nuclei) to total cells (brown + blue nuclei) (x100 to be expressed in percentage). Two independent investigators performed all counts in a blinded manner. The mean value was used for analysis.

Lung injury scoring

The lung injury was scored as previously reported [23]. Hematoxylin and eosin-stained sections were analyzed for neutrophil infiltration, airway epithelial-cell damage, interstitial edema, hyaline membrane formation, hemorrhage, and total lung injury score as the sum of those criterion. Each criterion was scored on a scale of 0 to 4, where 0 = normal, 1 = minimal change, 2 = mild change, 3 = moderate change, and 4 = severe change. Two independent investigators performed all counts in duplicate in a blinded manner.

Statistical analysis

All data were expressed as mean +/- SEM (standard error of the mean). The data were analyzed using a 2 factors analysis of variance (group x time) with repeated measures on time and interaction group x time. When the F ration reached a significant critical value (p < 0.05) a Fischer’s protected t-test was performed with a Bonferroni’s correction for multiple comparisons.

Using univariable and multivariable analyses with the Cox proportional hazard model, we tested the associations between the hemodynamic and inflammatory variables and the occurrence of PaO2/FiO2 ratio impairment and the occurrence of histological lung injury assessed by ALI score. Value of p<0.05 was considered statistically significant.

Results

Intracranial blood infusion was associated with an increase in intra-cranial pressure above 80 mmHg in 5 to 10 min and maintained subsequently higher than SAP. Adjustments were required during Cushing reflex-related hypertension that lasted 30 to 60 min.

Hemodynamic evaluation

Brain death

In the early phase (BD + 1h), brain death was associated with increased, PAP, pulmonary vascular resistance (PVR), PCP and venous component of PVR (Rv), HR, CO, noradrenaline need (used to maintain stable SAP), RAP and a decreased PaO2/FiO2 (Figs (Figs11 and and22).

Fig 1
Hemodynamic evaluation.
Fig 2
Hemodynamic evaluation.

In the late phase (BD + 5h), brain death was associated with further increases in PVR, noradrenaline need, and with further decrease in PaO2/FiO2, with no further changes in HR, RAP, mean PAP, Rv, PCP, HR and RAP (Figs (Figs11 and and22).

Brain death was associated, with no change in SAP (maintained with significant and progressive increase in noradrenaline need) and in PAWP (Figs (Figs11 and and22).

Brain death after methylprednisolone pretreatment

Pretreatment with methylprednisolone did not prevent hemodynamic changes induced one hour after brain death (Figs (Figs11 and and22).

Five hours after Cushing reflex, methylprednisolone pretreatment prevented brain death-induced changes in PAP, PVR, PCP, HR, CO and noradrenaline need, and reduced changes in PaO2/FiO2 (Figs (Figs11 and and22).

Correlations

There was a significant correlation between PCP and PaO2/FiO2 (R = -0.4862; p<0.001) and between Rv and PaO2/FiO2 (R = -0.3358; p<0.05) (Fig 1).

Evaluation of acute lung injury (ALI)

Brain death

In the early (BD+1h) and the late (BD+5h) phases after brain death, the ALI score was increased (Fig 3).

Fig 3
Characterization of acute lung injury (Panel A) at baseline, one (BD + 1 hour) and five (BD + 5 hours) hours after Cushing reflex in the placebo-pretreated brain death (BD group; n = 11; red bars) and the methylprednisolone-pretreated brain death (BD ...

Brain death after methylprednisolone pretreatment

The increase in ALI Score was not prevented by methylprednisolone pretreatment (Fig 3).

Correlations

The ALI Score and PaO2/FiO2 were correlated (R = -0.4294; p<0.05) (Fig 3).

Evaluation of lung infiltration by neutrophils—Anti-myeloperoxidase (MPO) immunostaining. Brain death

Brain death, in the late phase (BD + 5h), was associated with increased number of extravascular neutrophils per mm2 [assessed by immunohistochemistry (MPO)] (Fig 4).

Fig 4
Evaluation of neutrophilic lung infiltration.

Brain death after methylprednisolone pretreatment

The increase in extravascular neutrophils in lung tissue was not affected by methylprednisolone pretreatment (Fig 4).

Lung expression of TNF-α and interleukins (e.g. IL-6, IL-10, IL-1β,IL-8)

Brain death

In the early phase (BD + 1h), brain death was associated with increased gene expression for IL-6, decreased TNF-α mRNA content with no changes in expression for IL-10, IL-1β and IL-8, resulting in increased pro-inflammatory IL-6 to IL-10 ratio (p<0.05) in total lung homogenates. There were no changes in lung protein content for IL-6, IL-10 and IL-1β (Fig 5).

Fig 5
Lung expression of TNF-α and cytokines in brain death (BD)-induced lung injury.

In the late phase (BD + 5h), brain death was associated with further increased gene expression for IL-10 and IL-8, with no changes in IL-1β, IL-6, TNF-α and pro-inflammatory IL-6/IL-10 mRNA content in total lung homogenates. There were no changes in lung protein content for IL-6, IL-10 and IL-1β (Fig 5).

Brain death after methylprednisolone pretreatment

At baseline, methylprednisolone pretreatment was associated with decreased lung gene expression of IL-1β andTNF-α (Fig 5).

In the early phase (BD + 1h), methylprednisolone pretreatment was associated with no change in cytokines expression in total lung homogenates (Fig 5).

In the late phase (BD + 5h), methylprednisolone pretreatment was associated with decreased lung gene expression for IL-10, IL-1β, TNF-α, IL-8 and pro-inflammatory IL-6/IL-10 (p<0.05 compared to placebo-treated brain death). Corticosteroids pretreatment was associated with decreased lung protein content of IL-6 and IL-1β (trend) (Fig 5).

Serum cytokine levels

Brain death

Brain death, was associated with progressive increase in IL-6 and IL-1β serum concentration during both early (BD + 1h) and late (BD + 5h) phases of brain death. No change in serum IL-10 level was observed (Fig 6).

Fig 6
Serum interleukin (IL)-6, IL-10 and IL-1β protein concentrations.

Brain death after methylprednisolone pretreatment

Methylprednisolone pretreatment prevented changes in IL-1 β serum concentration in the late phase of brain death but did not prevent changes in IL-6 serum concentrations (Fig 6).

Correlations

PCP was correlated to serum IL-6 (R = 0.3122; p<0.05) and IL-1β (R = 0.3283; p<0.05) concentrations (Fig 6).

Lung expression of cell adhesion molecules (e.g. ICAM-1 and VCAM-1).

Brain death

At both early (BD + 1h) and late (BD + 5h) phases of brain death, lung gene expression for ICAM-1 and VCAM-1 were not changed (Fig 7).

Fig 7
Relative lung mRNA expression of intercellular adhesion molecule (ICAM) and vascular cell adhesion molecule (VCAM)-1 at baseline, one (BD + 1 hour) and five (BD + 5 hours) hours after Cushing reflex in the placebo-pretreated brain death (BD group; n = ...

Brain death after methylprednisolone pretreatment

In the late phase (BD + 5h), methylprednisolone pretreatment was associated with decreased lung VCAM-1 gene expression (Fig 7).

Lung expression of oxidative stress molecules (e.g. HO-1, HIF-1α, GPx-1 and OXSR-1)

Brain death

Brain death was associated with increased lung expression for HO-1 in the early phase (BD + 1h) and with increased expression, five hours after Cushing reflex, for HIF-1α (Fig 8).

Fig 8
Oxidative-stress.

Brain death after methylprednisolone pretreatment

In the late phase of brain death (BD + 5h), methylprednisolone pretreatment prevented the increase in HIF-1α expression (Fig 8).

Lung activation of apoptotic processes

Brain death

Brain death was associated with no changes in the Bax/Bcl2 pro-apoptotic ratio, but to assess the execution and the termination of apoptotic processes, TUNEL staining was performed. As illustrated in Fig 9B, in the late phase, brain death was associated with diffuse apoptosis in lung parenchyma (in extravascular areas) (Fig 9).

Fig 9
Lung apoptosis in brain death (BD)-induced lung injury with and without methylprednisolone pretreatment.

Brain death after methylprednisolone pretreatment

At baseline, the pro-apoptotic Bax/Bcl-2 ratio was decreased after methylprednisolone pretreatment. TUNEL staining changes were not prevented by methylprednisolone pretreatment (Fig 9).

Multivariable analysis–ALI score and PaO2/FiO2

Multivariable analyses indicated PCP (R = -0.4767; p<0.05) and Rv (R = -0.5682; p<0.01) to be independent predictors of PaO2/FiO2 decrease at BD+1hr, and serum concentration of IL-6 to be independent factor (R = 0.6729; p<0.001) for PaO2/FiO2 decrease at BD + 5 hours.

In addition, multivariable analyses for ALI score indicated Rv (R = -0.5738; p<0.05) to be independent factor at BD + 1 hour, and lung gene expression for TNF-α (R = 0.5974; p<0.05) to be independent factor at BD + 5 hours.

Discussion

For the first time, the present results show that porcine brain death (BD)-induced lung injury is associated with initial pulmonary capillary hypertension with increased pulmonary venous resistance. Brain death is also associated with altered gas exchange and expression or release of a number of pro-inflammatory cytokines which can be partially prevented by methylprednisolone therapy.

The pigs were of female sex because our animal facility is not equipped to accept more aggressive and difficult to handle males. This is admittedly a limitation of our study.

The Literature on experimental animal brain death models remains limited. The most widely used method relies in inflation of a Foley’s balloon in the subdural space. But this method does not reproduce the potential damage caused by intracranial blood effusion, which is most often present in clinical brain death.

Clinical and animal studies on subarachnoid hemorrhage report on an influx of immune cells associated with an increase in cytokine levels in both cerebrospinal fluid and serum [24]. In patients with subarachnoid hemorrhage, both ICAM-1 and VCAM-1 were increased in cerebrospinal fluid and serum [25,26]. An increase in IL-6, IL-1β and TNF-α was also detected in the serum of these patients [24,27]. Furthermore, lungs from brain death donors with cranial trauma are more frequently associated with early acute rejection and chronic bronchiolitis obliterans [28], which suggests an important physiological role for intracranial hemorrhage.

Based on these observations, it seemed interesting to develop a large animal model closer to human physiology when brain death is the consequence of intracranial hemorrhage. Until now, only one study described a model of intracranial hemorrhage [29] but without investigation of associated lung injury.

Even if results assumed that the brain death donor’s lungs may physiologically improve over time with progressive restoration of lung endothelial integrity [30] and rapid alveolar fluid resorption favorized by high levels of adrenal epinephrine and by diabetes insipidus installation [31,32], early hemodynamic damage and progressive systemic inflammatory response with massive increase in serum cytokine levels [7] could have an crucial role on the severity and control of pulmonary reperfusion injury. We therefore choose to study and identify the primary initial pathophysiological and biological mechanisms implicated in this condition.

In the present study, brain death-induced lung injury was associated with moderate pulmonary hypertension, as mean PAP exceeded the diagnostic cut-off value of 25 mmHg by only 2 mmHg, but with an increase in PCP above the threshold of 20 mmHg known to determine the onset of hydrostatic lung edema [32,33]. Pro-inflammatory Il-6/Il-10 were increased with the first measurement of increased PCP, allowing for reasonable speculation that lung injury at this stage was already caused by both increased PCP and capillary permeability.

Cerebrovascular stroke is the first cause of death in organ donors [34]. Intracranial accumulation of blood and associated cerebral edema may be a cause of rapid increase in intra-cranial pressure and activates a Cushing reflex to preserve cerebral perfusion [16] as was reproduced in the present experiments. This has been shown to be associated with a huge sympathetic nervous system activation, which may increase PCP because of associate blood volume shift from the systemic to pulmonary circulations, left heart failure of severe hypertension and catecholamine-induced myocarditis, and pulmonary venous constriction [1,2,6,35]. The present study did not attempt to capture Cushing reflex-associated events, but focused specifically on lung injury after established brain death. At this stage, CO, PAWP, stroke volume were within normal limits and SAP was low, excluding left heart failure on myocarditis of increased afterload. Yet PCP was abnormally high, in the range > 20 mmHg known to be associated with hydrostatic lung edema [32,33]. A possible explanation for this finding is persistent catecholamine-induced increased pulmonary venous resistance, previously reported as “pulmonary venule adrenergic hypersensitivity” [2]. Similar observations have been reported in high-altitude pulmonary edema (HAPE), where hypoxia and cerebral edema concur to hypoxic pulmonary vasoconstriction including the pulmonary venous segment to increase PCP [36]. In this particular condition too, high dose corticosteroids prevent symptoms of cerebral edema as well as increased pulmonary vascular pressures and lung injury [37].

In this porcine model of brain death-induced lung injury as well as in HAPE [38], initial stress on the pulmonary capillaries possibly due to transiently increased filling pressures of the left heart and more persistent venous constriction is soon followed by an inflammatory reaction which increases capillary permeability [3941]. Broncho-alveolar lavage studies have reported on high pro-inflammatory cytokine concentration in broncho-alveolar lavage and serum and by increased polymorphonuclear cells and macrophages in the lungs after brain death [42,43]. This inflammatory response may be associated with an increased risk of chronic rejection after lung transplantation [12,43]. In the present study, we found early histologic signs of lung injury (evaluated as the acute lung injury score) with congestion, hemorrhage, and infiltration by neutrophils after brain death. This was accompanied by increased early lung expression of IL-6 and pro-inflammatory IL-6/IL-10, as well as by increased serum levels of IL-6 and IL-1β. This is consistent with previous studies suggesting that, these pro-inflammatory cytokines play a significant role in perpetuating lung injury [42,44,45] and supported by the results of multivariate analysis applied for ALI-score and PaO2/FiO2. IL-6, which is produced by many different cell types, such as macrophages, T- and B-lymphocytes and endothelial cells [46], is a pleiotropic cytokine influencing antigen-specific immune responses and inflammatory reactions. Although IL-1β and TNF-α are physiologic stimuli for the synthesis of IL-6, we failed to find altered expression for them after brain death. Several studies have shown elevated lung TNF-α and IL-1β expression [42,47,48] or no significant change in lung tissue TNF-α and IL-1β expression [49], suggesting variable expression of these cytokines after brain death. Lung tissue expression in IL-6 and pro-inflammatory IL-6/IL-10 returned to normal level five hours after brain death, suggesting their implication as an early inflammatory response to hemodynamic stress.

Transcription of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) is induced by TNF-α and IL-1β [50]. The expressions of ICAM-1 and VCAM-1 have been reported to be increased in toxic and BD-induced models of acute lung injury [48,49] but remained unchanged in the present study as reported by other authors [48]. The activation of apoptosis suggested by the increased lung apoptotic rate measured by TUNEL immunochemistry in the present study is also consistent with previous reports [51] and seems to be closely related to the activation of inflammatory processes.

Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) have been shown to be associated with an imbalance of cytokines, oxidative stress, and apoptosis [52]. TNF-α, IL-1β, and IL-6, have been shown to participate in the early development of inflammation, contacting and sequestrating neutrophils and lymphocytes that play crucial roles in the development and the maintenance of the conditions [53,54]. In a same way, in this study, we have measured lung tissue overexpression of IL-8 with an early imbalance in IL-6 to IL-10 ratio and an important lung tissue neutrophilic infiltration five hours after brain death.

Interestingly, IL-8 has been shown to be the predominant neutrophil chemokine present in the distal airspaces of patients with ALI and is a predictor of mortality in these patients [55,56]; blocking IL-8 significantly attenuates lung injury caused by acid aspiration or ischemia-reperfusion injury [57]. On another hand, neutrophils retention in the pulmonary capillary bed could lead to pulmonary microcirculation for mechanical obstruction, and the neutrophils could release a large number of inflammatory factors and oxidative stress which may increase the lung injury [58].

A growing number of studies have found that excessive production of Reactive oxygen species (ROS) and reduction of antioxidant defense systems play important roles in the pathogenesis of ALI [59]. Imbalance of oxidation and antioxidation mechanisms due to neutrophil activation and accumulation in the lung may produce large amounts of ROS causing direct damage to alveolar epithelial cells and pulmonary vascular endothelial cells with blood barrier integrity destroying and increased permeability, leading to pulmonary edema. Moreover, ROS activate the expression of NF-κB, which is known to play the most crucial role in cell apoptosis [60].

Because oxidative stress in lung tissue has been also considered to be important contributors to the pathogenesis of ALI [61], in this study, we have used lung tissues gene expression in hypoxia inducible factor-1-alpha (HIF-1α), heme oxygenase-1 (HO-1), glutathion peroxidase-1 (GPx-1), oxidative-stress responsive-1 (OXSR-1) as indicators to explore the potential oxidative stress role in brain death-induced lung injury in our model.

Under hypoxic conditions, oxygen-sensing machinery activates a transcription factor known as hypoxia-inducible factor 1 (HIF-1). This factor switches on a series of genes participating in compensatory mechanisms that support cell survival in a potentially lethal microenvironment as heme-oxygenase (HO)-1 [62]. Both HO-1 and HIF-1α were increased, in this study, suggesting activation of protective pathways against oxidative stress in brain death-induced lung injury in our model associated with dramatically decreased PaO2/FiO2.

It is generally believed that donor resuscitation with corticosteroids improves the inflammatory response to brain death. In the present study, pre-treatment with methylprednisolone improved pulmonary hemodynamics and gas exchange in brain death animals. Likewise, preventive dexamethasone treatment prevented pulmonary hypertension and associated increase in PCP, improved blood gases and preserved susceptible individuals from the development of HAPE [37]. Methylprednisolone could prevent increases in PAP and PCP by a decrease in venous resistance as shown in oleic acid lung injury [63] in part in relation to a still incompletely understood sympatholytic effect [37]. At pathobiological level, methylprednisolone pretreatment decreased IL-6/IL-10, IL-1β, IL-8, TNF-α and vascular cell adhesion protein (VCAM)-1, as well as decreased serum IL-1β level. However, it did not prevent acute lung injury associated to brain death. It could be partially explained by the absence of effects of methylprednisolone pretreatment on the oxidative stress markers. The administration of methylprednisolone 60-min after brain death in donor rats has been shown to reduce inflammatory activity in transplanted lungs, but has no influence on parameters related to oxidative stress [64]. Methylprednisolone has been, reported to limit endothelial cell damage [65] and therefore to prevent increased lung vascular permeability in experimental endotoxemia [66]. This mechanism could contribute to improve PaO2/FiO2 in the present experimental model of brain death, as suggested by inverse correlation between PCP and PaO2/FiO2.

Conclusions

This study shows that brain death-induced lung injury is associated with initial pulmonary capillary hypertension with increased pulmonary venous resistance, what is shown for the first time, as a cause of altered gas exchange and expression or release of a number of pro-inflammatory cytokines which can partially prevented by vasodilating effects and anti-inflammatory actions of methylprednisolone therapy (Fig 10).

Fig 10
Findings summarize of the study.

Supporting information

S1 Data

Datasets used and analyzed in the current study.

Brain death (BD), heart rate (HR), cardiac output (CO), systemic arterial pressure (SAP), right atrial pressure (RAP), Noradrenaline Need, pulmonary artery wedge pressure (PAWP), pulmonary artery pressure (PAP), pulmonary vascular resistance (PVR), pulmonary capillary pressure (PCP), venous compartmental resistance (Rv), arterial PO2 divided by the fraction of inspired O2 (PaO2/FiO2), acute lung injury score (ALI Score), anti-myeloperoxidase immunostaining (MPO), interleukin 1β (IL-1β), interleukin 6 (IL-6), interleukin 10 (IL-10), interleukin 8 (IL-8), ribosomal protein L4 (RPL-4), TATA box binding protein (TBP-1), tumor necrosis factor alpha (TNF-α), Bcl2 associated X protein (Bax), B-cell Lymphoma-2 (Bcl-2), intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), heme oxygenase (HO-1), hypoxia inducible factor alpha (HIF-1α), Glutathion peroxidase 1 (GPx-1), Oxidative stress response 1 (OXSR-1).

(XLSX)

Abbreviations

ACTB
Actin beta
ALI
Acute Lung Injury
Bax
Bcl2 associated X protein
Bcl-2
B-cell Lymphoma-2
BD
Brain death
CO
Cardiac output
CR
Cushing reflex
CS
Corticosteroids
ELISA
Enzyme-Linked ImmunoSorbent Assay
FiO2
Fraction of inspired oxygen
GPx
Glutathion peroxidase
HAPE
High-altitude pulmonary edema
HIF
Hypoxia inducible factor
HO-
Heme oxygenase
HPRT
Hypoxanthine phosphoribosyl transferase
HR
Heart rate
ICAM
Intercellular adhesion molecule
IL
Interleukin
IL-19
Interleukin 19
OXSR
Oxidative stress response
PaO2
Arterial pressure in Oxygen
PAP
Pulmonary artery pressure
PAWP
Wedge pulmonary artery pressure
Pcap
Pulmonary capillary pressure
PEEP
Positive end-expiratory pressure
PVR
Pulmonary vascular resistance
Q
Instantaneous pulmonary blood flow
RAP
Right arterial pressure
RPL4
Ribosomal protein L4
Rv
Venous component of pulmonary vascular resistance
SaO2
Arterial oxygen saturation
SAP
Systemic artery pressure
TBP1
TATA box binding protein
TNF-
Tumor Necrosis Factor
TUNEL
Terminal Deoxynucleotidyl Transferase dUTP Nick-End Labelling
VCAM
Vascular cell adhesion molecule

Funding Statement

This work was supported by grants from Fonds de la Recherche Scientifique Medicale (grant no. 3.4515.05), the Belgian Foundation for the cardiac surgery and the Fondation Mont- Godinne(Belgium). AB is a fellow of the Fondation Mont- Godinne (Belgium). LD was a FNRS post-doctoral fellow. CMMI is supported by the European Regional Development Fund and the Walloon Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Data Availability

Data Availability

All relevant data are within the paper and its Supporting Information file.

References

1. Davison DL, Terek M and Chawla LS. Neurogenic pulmonary edema. Crit Care 2012;16: 212 doi: 10.1186/cc11226 [PMC free article] [PubMed]
2. Fein IA and, Rackow EC. Neurogenic pulmonary edema. Chest 1982;81: 318–320. [PubMed]
3. Theodore J and Robin ED. Speculations on neurogenic pulmonary edema (NPE). Am Rev Respir Dis 1976;113: 405–411. doi: 10.1164/arrd.1976.113.4.405 [PubMed]
4. Demling R, Riessen R. Pulmonary dysfunction after cerebral injury. Crit Care Med. 1990;18: 768–74. [PubMed]
5. Connor RC. Myocardial damage secondary to brain lesions. Am Heart J. 1969;78: 145–8. [PubMed]
6. Sarnoff SJ and Sarnoff LC. Neurohemodynamics of pulmonary edema. II. The role of sympathetic pathways in the elevation of pulmonary and stemic vascular pressures following the intracisternal injection of fibrin. Circulation. 1952;6: 51–62. [PubMed]
7. Avlonitis VS, Wigfield CH, Golledge HDR, Kirby JA, Dark JH. Early hemodynamic injury during donor brain death determines the severity of primary graft dysfunction after lung transplantation. Am J Transplant. 2007;7: 83–90. doi: 10.1111/j.1600-6143.2006.01593.x [PubMed]
8. Rostron AJ, Avlonitis VS, Cork DMW, Grenade DS, Kirby JA, Dark JH. Hemodynamic resuscitation with arginine vasopressin reduces lung injury after brain death in the transplant donor. Transplantation. 2008;85: 597–606 doi: 10.1097/TP.0b013e31816398dd [PubMed]
9. Van Raemdonck D, Neyrinck A, Verleden GM, Dupont L, Coosemans W, Decaluwé H, et al. Lung donor selection and management. Proc Am Thorac Soc. 2009;6: 28–38. doi: 10.1513/pats.200808-098GO [PubMed]
10. Belhaj A, Dewachter L, Rorive S, Remmelink M, Weynand B, Melot C et al. Roles of inflammation and apoptosis in experimental brain death-induced right ventricular failure. J Heart Lung Transplant. 2016;S1053–2498. [PubMed]
11. Baconnier PF, Eberhard A and Grimbert FA. Theoretical analysis of occlusion techniques for measuring pulmonary capillary pressure. J Appl Physiol 1992;73: 1351–9. [PubMed]
12. Avlonitis VS, Wigfield CH, Kirby JA and Dark JH. The hemodynamic mechanisms of lung injury and systemic inflammatory response following brain death in the transplant donor. Am J Transplant 2005;5: 684–693. doi: 10.1111/j.1600-6143.2005.00755.x [PubMed]
13. Butt Y, Kurdowska A and Allen TC. Acute lung injury. A clinical and molecular review. Arch Pathol Lab Med 2016;140: 345–350. doi: 10.5858/arpa.2015-0519-RA [PubMed]
14. Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci 1998;94: 557–572. [PubMed]
15. Follette DM, Rudich SM and Babcock WD. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant 1998;17: 423–429. [PubMed]
16. Fodstad H, Kelly PJ and Buchfelder M. History of the Cushing reflex. Neurosurgery 2006;59: 1132–1137. doi: 10.1227/01.NEU.0000245582.08532.7C [PubMed]
17. Morenski JD, Oro JJ, Tobias JD and Singh A. Determination of death by neurological criteria. J Intensive Care Med 2003;18: 211–21. doi: 10.1177/0885066603254359 [PubMed]
18. Scott JB, Gentile MA, Bennett SN, Couture M and MacIntyre NR. Apnea testing during brain death assessment: a review of clinical practice and published literature. Respir Care 2013;58: 532–538. doi: 10.4187/respcare.01962 [PubMed]
19. Fesler P, Pagnamenta A, Vachiéry JL, Brimioulle S, Abdel Kafi S, Boonstra A et al. Single arterial occlusion to locate resistance in patients with pulmonary hypertension. Eur Respir J 2003;21: 31–36. [PubMed]
20. Nygard A- B, Jørgensen CB, Cirera S and Fredholm M. Selection of reference genes for gene expression studies in pig tissues using SYBR green qPCR. BMC Mol Biol 2007;8: 67 doi: 10.1186/1471-2199-8-67 [PMC free article] [PubMed]
21. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29: e45 [PMC free article] [PubMed]
22. Dewachter C, Dewachter L, Rondelet B, Fesler P, Brimioulle S, Kerbaul F et al. Activation of apoptotic pathways in experimental acute afterload-induced right ventricular failure. Crit Care Med 2010;38: 1405–1413. doi: 10.1097/CCM.0b013e3181de8bd3 [PubMed]
23. Hong SB, Koh Y, Lee IC, Kim MJ, Kim WS, Kim DS et al. Induced hypothermia as a new approach to lung rest for the acutely injured lung. Crit Care Med 2005;33: 2049–55. [PubMed]
24. Fassbender K, Hodapp B, Rossol S, Bertsch T, Schmeck J, Schütt S et al. Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry. 2001;70: 534–7. doi: 10.1136/jnnp.70.4.534 [PMC free article] [PubMed]
25. Rothoerl RD, Schebesch K-M, Kubitza M, Woertgen C, Brawanski A, Pina A-L. ICAM-1 and VCAM-1 expression following aneurysmal subarachnoid hemorrhage and their possible role in the pathophysiology of subsequent ischemic deficits. Cerebrovasc Dis. 2006;22: 143–9. doi: 10.1159/000093243 [PubMed]
26. Xie X, Wu X, Cui J, Li H, Yan X. Increase ICAM-1 and LFA-1 expression by cerebrospinal fluid of subarachnoid hemorrhage patients: involvement of TNF-α. Brain Res. 2013;1512: 89–96. doi: 10.1016/j.brainres.2013.03.041 [PubMed]
27. Osuka K, Suzuki Y, Tanazawa T, Hattori K, Yamamoto N, Takayasu M et al. Interleukin-6 and development of vasospasm after subarachnoid haemorrhage. Acta Neurochir. 1998;140: 943–51. [PubMed]
28. Ciccone AM, Stewart KC, Meyers BF, Guthrie TJ, Battafarano RJ, Trulock EP et al. Does donor cause of death affect the outcome of lung transplantation? J Thorac Cardiovasc Surg. 2002;123: 429–34. [PubMed]
29. Hvas CL, Nielsen TK, Barklin A, Sørensen JC, Pedersen M, Andersen G et al. Brain death induced by cerebral haemorrhage—a new porcine model evaluated by CT angiography. Acta Anaesthesiol Scand. 2012;56: 995–1005. doi: 10.1111/j.1399-6576.2012.02682.x [PubMed]
30. Elliott AR, Fu Z, Tsukimoto K, Prediletto R, Mathieu-Costello O, West JB. Short-term reversibility of ultrastructural changes in pulmonary capillaries caused by stress failure. J Appl Physiol. 1992;73: 1150–8. [PubMed]
31. Maron MB, Holcomb PH, Dawson CA, Rickaby DA, Clough AV, Linehan JH. Edema development and recovery in neurogenic pulmonary edema. J Appl Physiol. 1994;77: 1155–63. [PubMed]
32. Guyton AC and Lindsey AW. Effect of elevated left atrial pressure and decreased plasma protein concentration on the development of pulmonary edema. Circ Res 1959;7: 649–657. [PubMed]
33. Scillia P, Delcroix M, Lejeune P, Mélot C, Struyven J, Naeije R et al. Hydrostatic pulmonary edema: evaluation with thin-section CT in dogs. Radiology 1999;211: 161–168. doi: 10.1148/radiology.211.1.r99ap07161 [PubMed]
34. Lund LH, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Goldfarb S et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Heart Transplantation Report-2015; Focus Theme: Early Graft Failure. J Heart Lung Transplant 2015;34: 1244–1254. doi: 10.1016/j.healun.2015.08.003 [PubMed]
35. Shivalkar B, Van Loon J, Wieland W, Tjandra-Maga TB, Borgers M, Plets C et al. Variable effects of explosive or gradual increase of intracranial pressure on myocardial structure and function. Circulation 1993;87: 230–239. [PubMed]
36. Maggiorini M, Mélot C, Pierre S, Pfeiffer F, Greve I, Sartori C et al. High-altitude pulmonary edema is initially caused by an increase in capillary pressure. Circulation 2001;103: 2078–2083. [PubMed]
37. Maggiorini M, Brunner-La Rocca HP, Peth S, Fischler M, Böhm T, Bernheim A et al. Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann Intern Med 2006;145: 497–506. [PubMed]
38. Swenson ER, Maggiorini M, Mongovin S, Gibbs JS, Greve I, Mairbäurl H et al. Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor. JAMA 2002;287: 2228–2235. [PubMed]
39. Maron MB. Effect of elevated vascular pressure transients on protein permeability in the lung. J Appl Physiol 1989;67: 305–310. [PubMed]
40. McClellan MD, Dauber IM and Weil JV. Elevated intracranial pressure increases pulmonary vascular permeability to protein. J Appl Physiol 1989;67: 1185–1191. [PubMed]
41. Rassler B, Reissig C, Briest W, Tannapfel A and Zimmer HG. Pulmonary edema and pleural effusion in norepinephrine-stimulated rats—hemodynamic or inflammatory effect. Mol Cell Biochem 2003;250: 55–63. [PubMed]
42. Cypel M, Kaneda H, Yeung JC, Anraku M, Yasufuku K, de Perrot M et al. Increased levels of interleukin-1β and tumor necrosis factor-α in donor lungs rejected for transplantation. J Heart Lung Transplant 2011;30: 452–459. doi: 10.1016/j.healun.2010.11.012 [PubMed]
43. Zweers N, Petersen AH, van der Hoeven JA, de Haan A, Ploeg RJ, de Leij LF et al. Donor brain death aggravates chronic rejection after lung transplantation in rats. Transplantation 2004;78: 1251–1258. [PubMed]
44. Meduri GU, Headley S, Kohler G, Stentz F, Tolley E, Umberger R et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 1995;107: 1062–1073. [PubMed]
45. Parsons PE, Eisner MD, Thompson BT, Matthay MA, Ancukiewicz M, Bernard GR et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 2005;33: 1–6. [PubMed]
46. Yasukawa H, Ohishi M, Mori H, Murakami M, Chinen T, Aki D et al. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat Immunol 2003;4: 551–556. doi: 10.1038/ni938 [PubMed]
47. Pilla ES, Pereira RB, Forgiarini Junior LA, Forgiarini LF, Paludo Ade O, Kulczynski JM et al. Effects of methylprednisolone on inflammatory activity and oxidative stress in the lungs of brain-dead rats. J Bras Pneumol 2013;39: 173–180. doi: 10.1590/S1806-37132013000200008 [PMC free article] [PubMed]
48. Skrabal CA, Thompson LO, Potapov EV, Southard RE, Joyce DL, Youker KA et al. Organ-specific regulation of pro-inflammatory molecules in heart, lung, and kidney following brain death. J Surg Res 2005;123: 118–125. doi: 10.1016/j.jss.2004.07.245 [PubMed]
49. Valenza F, Coppola S, Froio S, Ruggeri GM, Fumagalli J, Villa AM et al. A standardized model of brain death, donor treatment, and lung transplantation for studies on organ preservation and reconditioning. Intensive Care Med Exp 2014;2: 12 doi: 10.1186/2197-425X-2-12 [PMC free article] [PubMed]
50. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D and Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J. 1995;9: 899–909. [PubMed]
51. Zhou H, Liu J, Pan P, Jin D, Ding W and Li W. Carbon monoxide inhalation decreased lung injury via anti-inflammatory and anti-apoptotic effects in brain death rats. Exp Biol Med 2010;235: 1236–1243. [PubMed]
52. Liu H, Yu X, Yu S and Kou J. Molecular mechanisms in lipopolysaccharide-induced pulmonary endothelial barrier dysfunction. International Immunopharmacology. 2015;29: 937–946. doi: 10.1016/j.intimp.2015.10.010 [PubMed]
53. Carey PD, Jenkins JK, Byrne K, Walsh CJ, Fowler AA and Sugerman HJ. The neutrophil respiratory burst and tissue injury in septic acute lung injury: the effect of cyclooxygenase inhibition in swine. Surgery. 1992;112: 45–55. [PubMed]
54. Preira P, Forel JM, Robert P, Nègre P, Biarnes-Pelicot M, Xeridat F et al. The leukocyte-stiffening property of plasma in early acute respiratory distress syndrome (ARDS) revealed by a microfluidic single-cell study: The role of cytokines and protection with antibodies. Crit Care. 2016;20:8 doi: 10.1186/s13054-015-1157-5 [PMC free article] [PubMed]
55. Donnelly SC, Strieter RM, Kunkel SL, Walz A, Robertson CR, Carter DC et al. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 1993;341: 643–647. [PubMed]
56. Kurdowska A, Miller EJ, Noble JM, Baughman RP, Matthay MA, Brelsford WG et al. Anti-IL-8 autoantibodies in alveolar fluid from patients with the adult respiratory distress syndrome. J. Immunol. 1996;157: 2699–2706. [PubMed]
57. Modelska K, Pittet JF, Folkesson HG, Courtney Broaddus V and Matthay MA. Acid-induced lung injury. Protective effect of anti-interleukin-8 pretreatment on alveolar epithelial barrier function in rabbits. Am. J. Respir. Crit. Care Med. 1999;160: 1450–1456. doi: 10.1164/ajrccm.160.5.9901096 [PubMed]
58. Haslett C, Worthen GS, Giclas P C, Morrison DC, Henson JE and Henson PM. The pulmonary vascular sequestration of neutrophils in endotoxemia is initiated by an effect of endotoxin on the neutrophil in the rabbit. The American Review of Respiratory Disease. 1987;136: 9–18. doi: 10.1164/ajrccm/136.1.9 [PubMed]
59. Biswal S, Remick DG. Sepsis: redox mechanisms and therapeutic opportunities. Antioxidants & Redox Signaling. 2007;9: 1959–1961. [PMC free article] [PubMed]
60. Qi XF, Teng YC, Yoon YS, Kim DH, Cai DQ and Lee KJ. Reactive oxygen species are involved in the IFN-gamma-stimulated production of Th2 chemokines in HaCaT keratinocytes. Journal of Cellular Physiology. 2011;226: 58–65. doi: 10.1002/jcp.22303 [PubMed]
61. Zhang H, Slutsky AS and Vincent J-L. Oxygen free radicals in ARDS, septic shock and organ dysfunction. Intensive Care Medicine. 2000;26: 474–476. [PubMed]
62. Le WD, Xie WJ, and Appel SH. Protective role of heme oxygenase-1 in oxidative stress-induced neuronal injury. J. Neurosci. Res. 1999;56: 652–658. doi: 10.1002/(SICI)1097-4547(19990615)56:6<652::AID-JNR11>3.0.CO;2-5 [PubMed]
63. Hofman WF and Ehrhart IC. Methylprednisolone prevents venous resistance increase in oleic acid lung injury. J Appl Physiol Respir Environ Exerc Physiol 1983;54: 926–933. [PubMed]
64. Araujo LF, Holand AR, Paludo Ade O, Silva ÉF, Forgiarini LA, Forgiarini LF et al. Effect of the systemic administration of methylprednisolone on the lungs of brain-dead donor rats undergoing pulmonary transplantation. Clinics (Sao Paulo) 2014;69: 128–133. [PMC free article] [PubMed]
65. Smith LJ. The effect of methylprednisolone on lung injury in mice. Prevention of type 1 cell and endothelial cell damage. J Lab Clin Med 1983;101: 629–640. [PubMed]
66. Brigham KL, Bowers RE and McKeen CR. Methylprednisolone prevention of increased lung vascular permeability following endotoxemia in sheep. J Clin Invest 1981;67: 1103–1110. doi: 10.1172/JCI110123 [PMC free article] [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science